Year archive

NAVCO Pharmaceuticals — 2021 filings

All 24 regulatory filings released by NAVCO Pharmaceuticals (NAV) in 2021, sourced directly from the official regulator.

24 Filings

2021 Period

2021 filings (24)

Filing	Released	Lang
Management information circular - English.pdf Proxy Solicitation & Information Statement	2021-11-10	English
Form of proxy - English.pdf AGM Information	2021-11-10	English
Other.pdf Regulatory Filings	2021-11-10	English
Other.pdf AGM Information	2021-11-10	English
Notice of meeting - English.pdf AGM Information	2021-11-10	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2021-10-05	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2021-10-05	English
Annual MD&A - English.pdf Management Reports	2021-10-05	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf Regulatory Filings	2021-10-05	English
Audited annual financial statements – English.pdf Audit Report / Information	2021-10-05	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf Regulatory Filings	2021-10-05	English
Interim financial statements/report – English.pdf Regulatory Filings	2021-06-01	English
Interim MD&A - English.pdf Regulatory Filings	2021-06-01	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2021-06-01	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2021-06-01	English
News release - English.pdf Regulatory Filings	2021-04-16	English
Notice of the meeting and record date - English.pdf Proxy Solicitation & Information Statement	2021-04-06	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Management Reports	2021-03-02	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2021-03-02	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2021-03-02	English
Interim MD&A - English.pdf Interim / Quarterly Report	2021-03-02	English
Other.pdf M&A Activity	2021-01-19	English
Material change report - English.pdf Regulatory Filings	2021-01-19	English
News release - English.pdf Capital/Financing Update	2021-01-18	English